GL1X · GenesisL1 explorer

MolNFT v1 · #36369 · protein

Substrate envelope and drug resistance: crystal structure of R01 in complex with wild-type HIV-1 protease

2F3K: “Substrate envelope and drug resistance: crystal structure of R01 in complex with wild-type HIV-1 protease”. X-ray diffraction, 2 ligands (RO1, PO4), 1 pocket (best druggability 0.74). MolNFT v1 #36369 on GenesisL1: 3D structure…

PDB
2F3K
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03369
Ligands
RO1, PO4
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein994% helix, 54% strandP03369

Ligands and binding sites

  • RO1 · (3s,4as,8as)-N-(tert-butyl)-2-[(3S)-3-({3-(methylsulfonyl)-N-[(pyridin-3-yloxy)acetyl]-L-valyl}amino)-2-oxo-4-phenylbutyl]decahydroisoquinoline-3-carboxamide · ligand · chains A, B
  • PO4 · Phosphate ion · ion · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14300.740.8337RO1

Interfaces

1 interface between chains.

  • A–B · 1794 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 2F3K · Substrate envelope and drug resistance: crystal structure of r01 in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.